Phosphoramidite Market – A Global and Country Level Analysis: Focus on Type, End User, and Region – Analysis and Forecast, 2022-2032

$5,250$8,100

The global phosphoramidite market is projected to reach $2,062.9 million by 2032 from $900.3 million in 2021, at a CAGR of 7.78% during the forecast period 2022-2032.

SKU: BHL1254SA Category: Tag:

Description

Global Phosphoramidite Market: Industry Overview

The global phosphoramidite market is projected to reach $2,062.9 million by 2032 from $900.3 million in 2021, at a CAGR of 7.78% during the forecast period 2022-2032. The market growth can be ascribed to the rising demand for oligonucleotides, growing synthetic biology market, increasing partnerships and collaborations, continuous investment for research and development activities by private and public firms, and growing prevalence of several diseases creating an urgent need for novel therapeutic treatments.

Market Lifecycle Stage

The global phosphoramidite market is in the rapidly evolving and dynamic stage, which opens ample opportunities for life sciences companies. Also, companies that are already in the development phase for phosphoramidite are trying to bring diverse manufacturing options to the market to improve the quality of oligonucleotides. The companies operating in the global phosphoramidite market are now focusing more on high-quality and customized options. Also, major players such as Merck KGaA, Maravai LifeSciences Holdings, Inc, LGC Science Group Holdings Limited, and Thermo Fisher Scientific Inc. are investing heavily in research and development for their respective phosphoramidite products.

Impact

Before the discovery of phosphoramidites in 1981, deoxyribonucleic acid (DNA) synthesis techniques were restricted in the quality of DNA produced. Inefficient reactions generated truncated oligonucleotide sequences. Additionally, intermediates utilized in the synthesis process were highly unstable, predisposing the growing oligonucleotide sequence to damage. Together, several characteristics of phosphoramidites have enabled the chemistry to work well for a long time. Phosphoramidite chemistry is of fundamental importance for producing synthetic oligonucleotides that can be further utilized in a range of different areas, for instance, as primers for a polymerase chain reaction, oligonucleotide-based therapies, and genetic engineering. Millions of synthetic oligonucleotides are employed in research laboratories, pharmaceutical industries, and hospitals.

The phosphoramidite chemistry is unlikely to be replaced by emerging technologies, as the demand for primers and short-length DNA sequences is burgeoning within pharmaceuticals, synthetic biology, and molecular diagnostic industries. Essentially, synthetic DNA is applied for the discovery and engineering of biological pathways, making DNA synthesis a breakthrough of the last century. Thus, the market is anticipated to grow significantly during the forecast period 2022-2032.

Market Segmentation

Segmentation 1: by Type

• DNA Phosphoramidites
• RNA Phosphoramidites
• Labeled Phosphoramidites
• Others

Growing research and development activities and demand within the synthetic biology, pharmaceutical, diagnostic, and other industries are increasing the adoption of DNA phosphoramidites. Therefore, the type segment is dominated by DNA phosphoramidites, which held a share of 74.30% in 2021.

Segmentation 2: by End User

• Pharmaceutical and Biotechnology Companies
• Diagnostic Laboratories
• Synthetic Biology and Research Institutes

Among all three segments of end users, the pharmaceutical and biotechnology companies segment accounted for the largest share, holding 47.50% of the market in 2021.

Segmentation 3: by Region

• North America
• Europe
• Asia-Pacific
• Rest-of-the-World

North America is expected to dominate the global phosphoramidite market during the forecast period 2022-2032.

Recent Developments in the Global Phosphoramidite Market

• In August 2019, the company acquired 75% ordinary capital of the parent company of Toronto Research Chemicals Inc., i.e., Biomed Pharmaceutical Limited.
• In July 2022, TriLink BioTechnologies expanded its R&D leadership team’s responsibility for leading the company’s scientific direction and research and development strategy.
• In May 2022, TriLink BioTechnologies announced a cooperative agreement with the Department of Defense and included funding for TriLink’s expansion in San Diego, California, for nucleic acid production.
• In November 2021, Biosynth Carbosynth acquired Kexing Biopharmaceutical Co., Ltd.’s raw material manufacturing unit located in Jinan, China, to expand its operations and deliver a wide range of products at a larger production volume and increased capacity. The facility extends to more than 30,000 square meters of area.
• In November 2021, a leading investment firm, KKR, invested an undisclosed amount and acquired Biosynth Carbosynth from its founders, Armira and Dr. Urs Spitz. However, senior management will retain a significant ownership stake, and KKR will contribute as a strategic partner. KKR plans to encourage and accelerate the company’s product portfolio expansion and geographic buildout and widen its capabilities.

Demand – Drivers and Limitations

Following are the demand drivers for the global phosphoramidite market:

• Increasing Synthetic Nucleotide Applications in Therapeutics
• Growth in Synthetic Biology

The market is expected to face some limitations due to the following challenges:

• Challenges in Developing Long Nucleotide Sequences
• Competition from Emerging DNA Synthesis Technologies

How can this report add value to an organization?

Innovation Strategy: The global phosphoramidite report can help the reader gain a holistic view of the current and future global phosphoramidite market, including the competitive landscape, market size, and factors impacting the industry.

Growth/Marketing Strategy: The global phosphoramidite market has seen major development by key players operating in the market, such as acquisitions, business expansion and funding, and other developments. The favored strategy for the companies has been business expansion activities along with acquisitions to strengthen their position in the market.

Competitive Strategy: Key players in the global phosphoramidite market have been analyzed and profiled in the study. Moreover, a detailed competitive benchmarking of players operating in the global phosphoramidite market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as partnerships, agreements, and collaborations will aid the reader in understanding the untapped revenue pockets in the market.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, and market penetration.

Some of the prominent names in this market are:

• Biosynth Carbosynth
• Bioneer Corporation
• Lumiprobe Corporation
• QIAGEN N.V.
• Danaher Corporation (IDT)
• TriLink BioTechnologies
• Creative Biolabs
• PolyOrg, Inc.
• Hongene Biotech Corporation
• ChemGenes
• BOC Sciences
• Tokyo Chemical Industry Co., Ltd. (TCI)
• LGC Science Group Holdings Limited
• AAT Bioquest, Inc.
• Thermo Fisher Scientific, Inc.
• Merck KGaA

Additional information

Publisher

Geography Covered

Date Published

Pages

Format

Base Year

2022

Base Market Size

$974.7 Million in 2022

Currency

USD

Forecast Year

2032

Market Size Forecast

$2, 062.9 Million by 2032

CAGR

7.78%

Table of Contents

1 Market
1.1 Product Definition
1.2 Inclusion and Exclusion
2 Market Scope
2.1 Key Questions Answered in the Report
3 Research Methodology
3.1 Data Sources
3.1.1 Primary Data Source
3.1.2 Secondary Data Sources
3.2 Market Estimation Model
3.3 Criteria for Company Profiling
4 Market Overview
4.1 Introduction
4.2 Phosphoramidite Synthesis Process
4.2.1 Stability Considerations for Phosphoramidite
4.3 Applications of Phosphoramidite Chemistry
4.4 Future Trends in Phosphoramidite Industry
4.5 COVID-19 Impact on Phosphoramidite Industry
4.6 Current Market Size and Growth Potential, $Million, 2022-2032
5 Industry Insights
5.1 Overview
5.2 Regulatory Considerations for Phosphoramidite
5.2.1 Challenges
5.2.2 Current Regulatory Landscape
5.2.3 GMP, Control Strategy, and Facility Considerations
5.2.3.1 Brief Control Strategy
6 Market Dynamics
6.1 Overview
6.2 Impact Analysis
6.3 Market Drivers
6.3.1 Increasing Synthetic Nucleotide Applications in Therapeutics
6.3.2 Growth in Synthetic Biology
6.4 Market Restraints
6.4.1 Challenges in Developing Long Nucleotide Sequences
6.4.2 Competition from Emerging DNA Synthesis Technologies
6.5 Market Opportunities
6.5.1 Utilize advanced tools for lowering manufacturing cost and increasing production in gene synthesis
7 Global Phosphoramidite Market, by Type, $Million, 2021-2032
7.1 Overview
7.2 DNA Phosphoramidites
7.3 RNA Phosphoramidites
7.4 Labeled Phosphoramidites
7.5 Other Phosphoramidites
8 Global Phosphoramidite Market, by End Users, $Million, 2021-2032
8.1 Overview
8.2 Pharmaceutical and Biotechnology Companies
8.3 Diagnostic Laboratories
8.4 Synthetic Biology and Research Institutes
9 Global Phosphoramidite Market, by Region, $Million, 2021-2032
9.1 Overview
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 U.K.
9.3.2 Germany
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Rest-of-Europe
9.4 Asia-Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Rest-of-Asia-Pacific
9.5 Rest-of-the-World
10 Competitive Insights
10.1 Key Strategies and Development
10.1.1 Overview
10.1.2 Business Expansions
10.1.3 Mergers and Acquisitions
10.1.4 Funding Activities
10.1.5 Others
10.2 Market Share Analysis (by Company) 2021
11 Market – Competitive Benchmarking & Company Profiles
11.1 Overview
11.2 Biosynth Carbosynth
11.2.1 Company Overview
11.2.2 Role of Biosynth Carbosynth in the Global Phosphoramidite Market
11.2.3 Key Competitors of the Company
11.2.4 Corporate strategies
11.2.4.1 Synergistic Activities
11.2.5 Analyst Perspective
11.3 Bioneer Corporation
11.3.1 Company Overview
11.3.2 Role of Bioneer Corporation in the Global Phosphoramidite Market
11.3.3 Key Competitors of the Company
11.3.4 Analyst Perspective
11.4 Lumiprobe Corporation
11.4.1 Company Overview
11.4.2 Role of Lumiprobe Corporation in the Global Phosphoramidite Market
11.4.3 Key Competitors of the Company
11.4.4 Analyst Perspective
11.5 QIAGEN N.V.
11.5.1 Company Overview
11.5.2 Role of QIAGEN N.V. in the Global Phosphoramidite Market
11.5.3 Key Competitors of the Company
11.5.4 Financials
11.5.5 Analyst Perspective
11.6 Danaher Corporation (IDT)
11.6.1 Company Overview
11.6.2 Role of Danaher Corporation (IDT) in the Global Phosphoramidite Market
11.6.3 Key Competitors of the Company
11.6.4 Key Customers of the Company
11.6.5 Financials
11.6.6 Analyst Perspective
11.7 TriLink BioTechnologies
11.7.1 Company Overview
11.7.2 Role of TriLink BioTechnologies in the Global Phosphoramidite Market
11.7.3 Key Competitors of the Company
11.7.4 Financials
11.7.5 Business Strategies
11.7.6 Analyst Perspective
11.8 Creative Biolabs
11.8.1 Company Overview
11.8.2 Role of Creative Biolabs in the Global Phosphoramidite Market
11.8.3 Key Competitors of the Company
11.9 PolyOrg, Inc.
11.9.1 Company Overview
11.9.2 Role of PolyOrg, Inc. in the Global Phosphoramidite Market
11.9.3 Key Competitors of the Company
11.1 Hongene Biotech Corporation
11.10.1 Company Overview
11.10.2 Role of Hongene Biotech Corporation in the Global Phosphoramidite Market
11.10.3 Key Competitors of the Company
11.10.4 Business Strategies
11.11 ChemGenes
11.11.1 Company Overview
11.11.2 Role of ChemGenes in the Global Phosphoramidite Market
11.11.3 Key Competitors of the Company
11.12 BOC Sciences
11.12.1 Company Overview
11.12.2 Role of BOC Sciences in the Global Phosphoramidite Market
11.12.3 Key Competitors of the Company
11.12.4 Key Customers of the Company
11.13 Tokyo Chemical Industry Co., Ltd. (TCI)
11.13.1 Company Overview
11.13.2 Role of Tokyo Chemical Industry Co., Ltd. in the Global Phosphoramidite Market
11.13.3 Key Competitors of the Company
11.14 LGC Science Group Holdings Limited
11.14.1 Company Overview
11.14.2 Role of LGC Science Group Holdings Limited in the Global Phosphoramidite Market
11.14.3 Key Competitors of the Company
11.14.4 Key Customers of the Company
11.14.5 Financials
11.14.6 Business Strategies
11.14.7 Analyst Perspective
11.15 AAT Bioquest, Inc.
11.15.1 Company Overview
11.15.2 Role of AAT Bioquest, Inc. in the Global Phosphoramidite Market
11.15.3 Key Competitors of the Company
11.16 Thermo Fisher Scientific, Inc.
11.16.1 Company Overview
11.16.2 Role of Thermo Fisher Scientific, Inc. in the Global Phosphoramidite Market
11.16.3 Key Competitors of the Company
11.16.4 Financials
11.16.5 Analyst Perspective
11.17 Merck KGaA
11.17.1 Company Overview
11.17.2 Role of Merck KGaA in the Global Phosphoramidite Market
11.17.3 Key Competitors of the Company
11.17.4 Financials
11.17.5 Analyst Perspective
List of Figures
Figure 1: Global Phosphoramidite Market Dynamics
Figure 2: Global Phosphoramidite Market (by Type), $Million, 2021 and 2032
Figure 3: Global Phosphoramidite Market (by End User), $Million, 2021 and 2032
Figure 4: Global Phosphoramidite Market (by Region), $Million, 2021-2032
Figure 5: Global Phosphoramidite Market Segmentation
Figure 6: Global Phosphoramidite Market Research Methodology
Figure 7: Primary Research Methodology
Figure 8: Volume-Based Market Sizing and Forecasting Methodology
Figure 9: Structure of a Standard 2’-Deoxyadenosine Phosphoramidite
Figure 10: Workflow of Phosphoramdite Synthesis Chemistry to Produce Oligonucleotides
Figure 11: Phosphoramidite Synthesis Cycle
Figure 12: Factors Impacting the Stability of Phosphoramidites
Figure 13: Phosphoramidite Key Application Areas
Figure 14: Global Phosphoramidite Market, $Million, 2021-2032
Figure 15: Challenges for Phosphoramidite as a Drug Product
Figure 16: Control Strategy: Phosphoramidite Elements
Figure 17: Elements of Microbial Control Strategy
Figure 18: Details of GMP, Control Strategy, and Facility Considerations
Figure 19: Market Dynamics
Figure 20: Impact Analysis
Figure 21: Factors Influencing Rise in Oligonucleotide Demand and Growing Market
Figure 22: Breakthrough Achievements in Synthetic Biology, 2016-2020
Figure 23: Key Competitors Impacting Global Phosphoramidite Market Growth in Future
Figure 24: Share of Global Phosphoramidite Market (by Type), $Million, 2021 and 2032
Figure 25: Characteristics of DNA Phosphoramidites
Figure 26: Global Phosphoramidite Market (DNA Phosphoramidites), $Million, 2021-2032
Figure 27: Global Phosphoramidite Market (RNA Phosphoramidites), $Million, 2021-2032
Figure 28: Global Phosphoramidite Market (Labeled Phosphoramidites), $Million, 2021-2032
Figure 29: Global Phosphoramidite Market (Other Phosphoramidites), $Million, 2021-2032
Figure 30: Share of Global Phosphoramidite Market (by End User), $Million, 2021 and 2032
Figure 31: Global Phosphoramidite Market (Pharmaceutical and Biotechnology Companies), $Million, 2021-2032
Figure 32: Global Phosphoramidite Market (Diagnostic Laboratories), $Million, 2021-2032
Figure 33: Global Phosphoramidite Market (Synthetic Biology and Research Institutes), $Million, 2021-2032
Figure 34: Global Phosphoramidite Market (by Region), $Million, 2021-2032
Figure 35: Market Dynamics of North America Phosphoramidite Market
Figure 36: North America Phosphoramidite Market, $Million, 2021-2032
Figure 37: Projections of the Older Adult Population in the U.S.: 2016 to 2060 (Million)
Figure 38: U.S. Phosphoramidite Market, $Million, 2021-2032
Figure 39: Canada Phosphoramidite Market, $Million, 2021-2032
Figure 40: Market Dynamics of Europe Phosphoramidite Market
Figure 41: Europe Phosphoramidite Market, $Million, 2021-2032
Figure 42: U.K. Phosphoramidite Market, $Million, 2021-2032
Figure 43: Germany Phosphoramidite Market, $Million, 2021-2032
Figure 44: France Phosphoramidite Market, $Million, 2021-2032
Figure 45: Spain Phosphoramidite Market, $Million, 2021-2032
Figure 46: Italy Phosphoramidite Market, $Million, 2021-2032
Figure 47: Rest-of-Europe Phosphoramidite Market, $Million, 2021-2032
Figure 48: Market Dynamics of the Asia-Pacific Phosphoramidite Market
Figure 49: Asia-Pacific Phosphoramidite Market, $Million, 2021-2032
Figure 50: Japan Phosphoramidite Market, $Million, 2021-2032
Figure 51: China Phosphoramidite Market, $Million, 2021-2032
Figure 52: India Phosphoramidite Market, $Million, 2021-2032
Figure 53: Rest-of-APAC Phosphoramidite Market, $Million, 2021-2032
Figure 54: Rest-of-the-World Phosphoramidite Market, $Million, 2021-2032
Figure 55: Figure: Share of Key Developments, January 2019-August 2022
Figure 56: Business Expansions (by Company), January 2019-August 2022
Figure 57: Merger and Acquisition Activities (by Company), January 2019-August 2022
Figure 58: Market Share Analysis for the Global Phosphoramidite Market, 2021
Figure 59: Total Number of Companies Profiled
Figure 60: Bioneer Corporation’s Phosphoramidite Manufacturing Capacity
Figure 61: Bioneer Corporation: Selective Product Portfolio
Figure 62: Lumiprobe Corporation: Selective Product Portfolio
Figure 63: QIAGEN N.V.: Selective Product Profile
Figure 64: QIAGEN N.V.: Overall Financials, 2019-2021
Figure 65: QIAGEN N.V.: Revenue (by Segment), $Million, 2019-2021
Figure 66: QIAGEN N.V.: Revenue (by Region), $Million, 2019-2021
Figure 67: QIAGEN N.V.: R&D Expenditure, 2019-2021
Figure 68: Danaher Corporation (IDT): Selective Product Portfolio
Figure 69: Danaher Corporation (IDT): Overall Financials, $Million, 2019-2021
Figure 70: Danaher Corporation (IDT): Revenue (by Segment), $Million, 2019-2021
Figure 71: Danaher Corporation (IDT): Revenue (by Region), $Million, 2019-2021
Figure 72: Danaher Corporation (IDT), R&D Expenditure, $Million, 2019-2021
Figure 73: TriLink BioTechnologies: Selective Product Portfolio
Figure 74: Maravai LifeSciences Holdings, Inc.: Overall Financials, $Million, 2019-2021
Figure 75: Maravai LifeSciences Holdings, Inc.: Revenue (by Segment), $Million, 2019-2021
Figure 76: Maravai LifeSciences Holdings, Inc.: Revenue (by Region), $Million, 2019-2021
Figure 77: Maravai LifeSciences Holdings, Inc.: R&D Expenditure, $Million, 2019-2021
Figure 78: Creative Biolabs: Selective Product Portfolio
Figure 79: PolyOrg, Inc.: Selective Product Portfolio
Figure 80: Hongene Biotech Corporation: Selective Product Portfolio
Figure 81: ChemGenes: Selective Product Portfolio
Figure 82: BOC Sciences: Selective Product Portfolio
Figure 83: Tokyo Chemical Industry Co., Ltd.: Selective Product Portfolio
Figure 84: LGC Science Group Holdings Limited: Selective Product Portfolio
Figure 85: LGC Science Group Holdings Limited: Overall Financials, $Million, 2019-2021
Figure 86: LGC Science Group Holdings Limited: Revenue (by Region), $Million, 2019-2021
Figure 87: AAT Bioquest, Inc.: Selective Product Portfolio
Figure 88: Thermo Fisher Scientific, Inc.: Selective Product Portfolio
Figure 89: Thermo Fisher Scientific, Inc.: Overall Financials, 2019-2021
Figure 90: Thermo Fisher Scientific, Inc.: Revenue (by Segment), $Million, 2019-2021
Figure 91: Thermo Fisher Scientific, Inc.: Revenue (by Region), $Million, 2019-2021
Figure 92: Thermo Fisher Scientific, Inc.: R&D Expenditure, $Million, 2019-2021
Figure 93: Merck KGaA: Selective Product Portfolio
Figure 94: Merck KGaA: Overall Financials, $Million, 2019-2021
Figure 95: Merck KGaA: Revenue (by Segment), $Million, 2019-2021
Figure 96: Merck KGaA: Revenue (by Region), $Million, 2019-2021
Figure 97: Merck KGaA: R&D Expenditure, $Million, 2019-2021
List of Tables
Table 1: Companies and COVID-19 Impact
Table 2: Guideline Summary for Phosphoramidites
Table 3: Decreased Coupling Efficiency with Extending Oligonucleotide Sequence
Table 4: Key Characteristics of Enzymatic-based and Phosphoramidite Synthesis
Table 5: Examples of RNA Phosphoramidites
Table 6: List of Approved Oligonucleotide-Based Therapies, 1998-2020

Companies Mentioned

Biosynth Carbosynth
Bioneer Corporation
Lumiprobe Corporation
QIAGEN N.V.
Danaher Corporation (IDT)
TriLink BioTechnologies
Creative Biolabs
PolyOrg, Inc.
Hongene Biotech Corporation
ChemGenes
BOC Sciences
Tokyo Chemical Industry Co., Ltd. (TCI)
LGC Science Group Holdings Limited
AAT Bioquest, Inc.
Thermo Fisher Scientific, Inc.
Merck KGaA

Reviews

There are no reviews yet.

Be the first to review “Phosphoramidite Market – A Global and Country Level Analysis: Focus on Type, End User, and Region – Analysis and Forecast, 2022-2032”

[class^="wpforms-"]
[class^="wpforms-"]